Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency

NCT ID: NCT04139265

Last Updated: 2019-10-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

136 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-06-06

Study Completion Date

2019-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Transferrin saturation coefficient and ferritinemia in diagnosis of iron deficiency

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iron-deficiency Internal Medicine Transferrin Ferritinemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hospitalized patients aged 65 and over

\- Patients aged 65 and over hospitalized in the department of Internal Medicine and Geriatry

biologic analysis (ferritinemia, transferrin saturation coefficient)

Intervention Type DIAGNOSTIC_TEST

Each patient will follow a blood test in order to compare between ferritinemia and transferrin saturation coefficient in iron deficiency diagnosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

biologic analysis (ferritinemia, transferrin saturation coefficient)

Each patient will follow a blood test in order to compare between ferritinemia and transferrin saturation coefficient in iron deficiency diagnosis

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 65 years old
* Patient hospitalized in the internal medicine and geriatry service
* Patient affiliated with a social security scheme
* Patient signed an Informed consent

Exclusion Criteria

* Risk benefit balance not in favor of iron deficiency check-up
* Patient in palliative care
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lille Catholic University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hélène Bulckaen, MD

Role: PRINCIPAL_INVESTIGATOR

Groupement des Hôpitaux de l'Institut Catholique de Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Saint-Philibert hospital

Lomme, Nord, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC-P0079

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hemoglobin and Iron Recovery Study
NCT01555060 COMPLETED PHASE2
The Effect of Serum Ferritin in irAE
NCT06702566 RECRUITING NA